AI 요약
xeljanz xr에 대한 실시간 결과 27개를 검토하고, 먼저 비교할 가치가 높은 3개의 옵션로 좁혔습니다.
이 후보 목록에서 가장 강한 주제는 Prescription Drugs 및 Pharmaceutical입니다.
Compare with TopFind
라이브 검색
라이브 결과 로딩 중
TopFind가 검색어에 맞는 최신 결과를 가져오고 있습니다.
라이브 검색
TopFind가 검색어에 맞는 최신 결과를 가져오고 있습니다.
xeljanz xr에 대한 실시간 결과 27개를 검토하고, 먼저 비교할 가치가 높은 3개의 옵션로 좁혔습니다.
이 후보 목록에서 가장 강한 주제는 Prescription Drugs 및 Pharmaceutical입니다.
출처: Pfizer (Thailand) Ltd.
설명
XELJANZ XR is the extended-release formulation of tofacitinib, delivered in 11 mg tablets for once-daily dosing. It is indicated for the treatment of inflammatory conditions like rheumatoid arthritis and psoriatic arthritis where consistent medicine levels are required.
추천 대상
Once Daily dosing, Long Term maintenance 및 Chronic inflammation management
평점
출처: Watsons Philippines
설명
The 11mg extended-release (XR) version of Xeljanz (tofacitinib) offered by Watsons Philippines. This formulation provides a steady release of medication and is intended for patients requiring a higher once-daily dosage as prescribed by a medical professional.
추천 대상
Once Daily dosage users, Extended Release medication, Chronic inflammatory conditions 및 Online pharmacy users
평점
출처: Pfizer
설명
Xeljanz is a prescription Janus kinase (JAK) inhibitor used to treat adults with moderately to severely active rheumatoid arthritis (RA), psoriatic arthritis, and ulcerative colitis. As a brand-name pharmaceutical, it is available in 5mg immediate-release and 11mg extended-release (XR) tablet formulations designed to reduce inflammation and manage symptoms of autoimmune diseases.
추천 대상
Rheumatoid arthritis patients, Prescribed JAK inhibitors, Autoimmune disease management 및 Ulcerative colitis treatment
평점
| 비교 | XELJANZ XR | Xeljanz 11mg XR Tablet | Xeljanz (tofacitinib) |
|---|---|---|---|
| 출처 | Pfizer (Thailand) Ltd. | Watsons Philippines | Pfizer |
| 설명 | XELJANZ XR is the extended-release formulation of tofacitinib, delivered in 11 mg tablets for once-daily dosing. It is indicated for the treatment of inflammatory conditions like rheumatoid arthritis and psoriatic arthritis where consistent medicine levels are required. | The 11mg extended-release (XR) version of Xeljanz (tofacitinib) offered by Watsons Philippines. This formulation provides a steady release of medication and is intended for patients requiring a higher once-daily dosage as prescribed by a medical professional. | Xeljanz is a prescription Janus kinase (JAK) inhibitor used to treat adults with moderately to severely active rheumatoid arthritis (RA), psoriatic arthritis, and ulcerative colitis. As a brand-name pharmaceutical, it is available in 5mg immediate-release and 11mg extended-release (XR) tablet formulations designed to reduce inflammation and manage symptoms of autoimmune diseases. |
| 추천 대상 | Once Daily dosing, Long Term maintenance 및 Chronic inflammation management | Once Daily dosage users, Extended Release medication, Chronic inflammatory conditions 및 Online pharmacy users | Rheumatoid arthritis patients, Prescribed JAK inhibitors, Autoimmune disease management 및 Ulcerative colitis treatment |
| 작업 | |||
| 평점 |
가장 균형 잡힌 옵션부터 보고 싶다면 다음을 추천합니다:
"XELJANZ XR 출처 Pfizer (Thailand) Ltd.."
이 항목을 선택한 이유는 Offers the convenience of once-daily dosing through its extended-release formulation, supported by Pfizer's official clinical standards.